University of Mississippi Seeks License to Produce Marijuana for Research
Published Date: 10/19/2026
Notice
Summary
The National Center for Natural Products Research at the University of Mississippi wants to officially make large amounts of marijuana and related substances for research and product development. People who might be affected can share their thoughts or ask for a hearing by December 18, 2026. This move helps support scientific progress while keeping safety rules in check.
Analyzed Economic Effects
3 provisions identified: 2 benefits, 1 costs, 0 mixed.
University applied to bulk-manufacture Schedule I cannabis
On September 7, 2026, the National Center for Natural Products Research at the University of Mississippi applied to be registered as a bulk manufacturer of three Schedule I substances: Marihuana Extract (drug code 7350), Marihuana (drug code 7360), and Tetrahydrocannabinols (drug code 7370). The application says the planned activities are for product development and to produce reference standards.
Comment and hearing deadline: December 18, 2026
Registered bulk manufacturers of the affected drug classes and other applicants may submit electronic comments or objections through https://www.regulations.gov, or file a written request for a hearing, on or before December 18, 2026. After you submit a comment you will receive a Comment Tracking Number to confirm successful submission.
Authorized activities limited and extraction restricted
The application states that, for drug codes 7350 (Marihuana Extract) and 7370 (Tetrahydrocannabinols), the company plans to extract those substances from produced 7360 (Marihuana). The notice also states that no other activities for these drug codes are authorized for this registration.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11526, Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128, Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2025-05007, Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients
Starting December 31, 2025, veterans can get buprenorphine treatment and follow-up care through telemedicine, making it easier to access help for opioid use disorder without leaving home. This change affects veterans using VA health services and aims to improve treatment access while the government reviews feedback and policies. No new costs are mentioned, but the delay gives agencies time to ensure the rules work well.
2025-02793, Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients
The government is giving veterans easier access to buprenorphine treatment through telemedicine, letting them get care remotely. This change affects veterans using VA health services and aims to make treatment smoother and more convenient. The new rules were supposed to start February 18, 2025, but now they’ll kick in on March 21, 2025, while the government gathers public feedback.
2026-21354, Importer of Controlled Substances Application: DMS Pharmaceutical Group
DMS Pharmaceutical Group wants to become an official importer of fentanyl, a powerful controlled substance. People and companies involved with these drugs can share their thoughts or ask for a hearing by November 18, 2026. This move could impact how fentanyl is brought into the U.S., so keep an eye on the deadline if you’re involved!
2026-21369, Bulk Manufacturer of Controlled Substances Application: Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals wants to officially make a big batch of methylphenidate, a controlled drug, at their Georgia site. People who already make or use this drug can share their thoughts or ask for a hearing by December 18, 2026. This move could affect how the drug is produced and sold, but no extra activities are allowed beyond manufacturing for sale.
Previous / Next Documents
Previous: 2026-21358, Importer of Controlled Substances Application: National Center for Natural Products Research
The National Center for Natural Products Research wants to become an official importer of certain controlled substances, like marijuana. People and companies involved can share their thoughts or ask for a hearing by November 18, 2026. This move could impact researchers and businesses working with these substances, but no costs or fees are mentioned yet.
Next: 2026-21360, Bulk Manufacturer of Controlled Substances Application: Scottsdale Research Institute
Scottsdale Research Institute wants to make a big batch of ibogaine, a controlled substance, for research and clinical trials. People who already make or use this drug can comment or ask for a hearing by December 18, 2026. This move could speed up important medical studies without changing how the drug is sold or used commercially.